Next Article in Journal
Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations
Next Article in Special Issue
Evolving Paradigms in Acute Myeloid Leukemia: Personalized Approaches to Therapy Across Age and Risk Groups
Previous Article in Journal
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan
Previous Article in Special Issue
Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases
 
 
cancers-logo
Article Menu

Article Menu

Article

Article Versions Notes

Cancers 2025, 17(9), 1388; https://doi.org/10.3390/cancers17091388
Action Date Notes Link
article html file updated 22 April 2025 13:18 CEST Original file -
article xml file uploaded 22 April 2025 13:18 CEST Original file -
article xml uploaded. 22 April 2025 13:18 CEST Update https://www.mdpi.com/2072-6694/17/9/1388/xml
article pdf uploaded. 22 April 2025 13:18 CEST Version of Record https://www.mdpi.com/2072-6694/17/9/1388/pdf
article supplementary file uploaded. 22 April 2025 13:18 CEST - https://www.mdpi.com/2072-6694/17/9/1388#supplementary
article html file updated 25 June 2025 01:18 CEST Update -
article html file updated 28 August 2025 07:22 CEST Update https://www.mdpi.com/2072-6694/17/9/1388/html
Back to TopTop